10.22376/ijpbs.2019.10.1.p1-12 Volume 3 Issue 2 2012 (April - June) Supraventricular tachycardia (SVT) is an uncommon event in the NICU. It may result from underlying cardiac malformation, Wolf-Parkinson-White syndrome, arrhythmogenic drugs or idiopathic in nature. They may or may not result in hemodynamic compromise, nevertheless, need to be treated appropriately. Recurrent neonatal SVT needs prophylactic therapy for about 9 – 12 months, as they tend to resolve spontaneously beyond 1 year. Chandan Kumar Shaw Supraventricular tachycardia, WPW syndrome, adenosine, propranolol. 140-145